BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34853967)

  • 1. Simultaneous Administration of NOD-2 (MDP) and TLP-4 (LPS) Ligands to Bone Marrow Donors 24 h before Transplantation Increases the Content of Multipotent Stromal Cells (MSCs) in Bone Marrow Grafts in CBA Mice Compared to the Total Result of Their Isolated Administration.
    Gorskaya YF; Semenova EN; Nagurskaya EV; Bekhalo VA; Nesterenko VG
    Bull Exp Biol Med; 2021 Dec; 172(2):175-179. PubMed ID: 34853967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligands of NOD2 (Muramyl Dipeptide) and TLR4 (LPS) in 24 h after Combined In Vivo Administration Produce a Synergistic Increase in the Content of Multipotent Stromal Cells in the Bone Marrow and Peritoneal Exudate of CBA Mice.
    Gorskaya YF; Tukhvatulin AI; Dzharullaeva AS; Nesterenko VG
    Bull Exp Biol Med; 2019 Feb; 166(4):473-476. PubMed ID: 30788737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NLR2 and TLR3, TLR4, TLR5 Ligands, Injected In Vivo, Improve after 1 h the Efficiency of Cloning and Proliferative Activity of Bone Marrow Multipotent Stromal Cells and Reduce the Content of Osteogenic Multipotent Stromal Cells in CBA Mice.
    Gorskaya YF; Tukhvatulin AI; Nesterenko VG
    Bull Exp Biol Med; 2017 Jul; 163(3):356-360. PubMed ID: 28744636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Content of Multipotent Stromal Cells in 3-4.5-Month Heterotopic Bone Marrow Transplants of CBA Mice Subjected to a Single Exposure to Osteogenic Stimuli (Curettage, BMP-2) or Antigens (S. typhimurium antigenic complex, LPS).
    Gorskaya YF; Nesterenko VG
    Bull Exp Biol Med; 2017 May; 163(1):137-141. PubMed ID: 28577100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Activated Immunocompetent Cells on the Number of Multipotent Stromal Cells in Bone Marrow Transplants of CBA and CBA/N Mice in a Short Time after Polyvinylpyrrolidone Administration to Animals.
    Gorskaya YF; Tukhvatulin AI; Dzharullaeva AS; Semenova EN; Nagurskaya EV; Bekhalo VA; Nesterenko VG
    Bull Exp Biol Med; 2019 Jan; 166(3):348-352. PubMed ID: 30627912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Administration of TLR4 (LPS) and TLR3 (Poly I:C) Ligands to CBA Mice Elevates the Content of Osteogenic MSC by 1.6 Times and Increases Content of Bone Marrow MSC to Intermediate Level between Values Attained by Their Individual Administration.
    Gorskaya YF; Tukhvatulin AI; Dzharullaeva AS; Nesterenko VG
    Bull Exp Biol Med; 2020 Apr; 168(6):767-772. PubMed ID: 32328942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human umbilical cord blood mesenchymal stem cells reduce colitis in mice by activating NOD2 signaling to COX2.
    Kim HS; Shin TH; Lee BC; Yu KR; Seo Y; Lee S; Seo MS; Hong IS; Choi SW; Seo KW; Núñez G; Park JH; Kang KS
    Gastroenterology; 2013 Dec; 145(6):1392-403.e1-8. PubMed ID: 23973922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counts of MSC in the Bone Marrow of Young and Old CBA Mice after a Single Exposure to Osteogenic Stimuli (Curettage, BMP-2 Injection) or Antigens (S. typhimurium Antigenic Complex) and in Heterotopic Bone Marrow Transplants.
    Gorskaya YF; Dzharullaeva AS; Onsina DS; Nesterenko VG
    Bull Exp Biol Med; 2017 Jul; 163(3):365-369. PubMed ID: 28744638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nod2 and Rip2 contribute to innate immune responses in mouse neutrophils.
    Jeong YJ; Kang MJ; Lee SJ; Kim CH; Kim JC; Kim TH; Kim DJ; Kim D; Núñez G; Park JH
    Immunology; 2014 Oct; 143(2):269-76. PubMed ID: 24766550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of Bone Marrow Multipotent Stromal Cells in the Processes Presumably Provoking Vascular Calcification.
    Gorskaya YF; Semenova EN; Nagurskaya EV; Nesterenko VG
    Bull Exp Biol Med; 2020 Feb; 168(4):479-484. PubMed ID: 32146636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of NOD1 or NOD2 and TLR4 activation on mouse sickness behavior in relation to immune and brain activity markers.
    Farzi A; Reichmann F; Meinitzer A; Mayerhofer R; Jain P; Hassan AM; Fröhlich EE; Wagner K; Painsipp E; Rinner B; Holzer P
    Brain Behav Immun; 2015 Feb; 44():106-20. PubMed ID: 25218901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
    Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
    J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NOD2/CARD15 on bone marrow CD34+ hematopoietic cells mediates induction of cytokines and cell differentiation.
    Sioud M; Fløisand Y
    J Leukoc Biol; 2009 Jun; 85(6):939-46. PubMed ID: 19244164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicutaneous immunization with protein antigen TNP-Ig and NOD2 ligand muramyl dipeptide (MDP) reverses skin-induced suppression of contact hypersensitivity.
    Majewska-Szczepanik M; Dorożyńska I; Strzępa A; Szczepanik M
    Pharmacol Rep; 2014 Feb; 66(1):137-42. PubMed ID: 24905319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muramyl dipeptide enhances lipopolysaccharide-induced osteoclast formation and bone resorption through increased RANKL expression in stromal cells.
    Ishida M; Kitaura H; Kimura K; Sugisawa H; Aonuma T; Takada H; Takano-Yamamoto T
    J Immunol Res; 2015; 2015():132765. PubMed ID: 26000311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
    Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
    Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.
    Zhao L; Li G; Chan KM; Wang Y; Tang PF
    Calcif Tissue Int; 2009 Jan; 84(1):56-64. PubMed ID: 19052794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
    Le Contel C; Temime N; Charron DJ; Parant MA
    J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Nod2 Agonist Muramyl Dipeptide Cooperates with the TLR4 Agonist Lipopolysaccharide to Enhance IgG2b Production in Mouse B Cells.
    Lee SH; Park JH; Park SR
    J Immunol Res; 2019; 2019():2724078. PubMed ID: 31886297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of immunization with group a streptococcal antigens on the transplantability of mouse bone marrow stromal stem cells, counts of stromal precursor cells, and their osteogenic characteristics.
    Gorskaya YF; Danilova TA; Lebedinskaya OV; Lunin VG; Grabko VI; Sharapova NE; Nesterenko VG
    Bull Exp Biol Med; 2011 Sep; 151(5):607-11. PubMed ID: 22462057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.